Related Experiment Video
Updated: Jun 18, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Reduced Cost Sharing and Medication Management Services for COPD: A Randomized Clinical Trial
Sumit D Agarwal1,2, Elizabeth Metzler3, Michael Chernew2
1Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
A program reducing costs for maintenance inhalers and offering medication management significantly improved adherence for chronic obstructive pulmonary disease (COPD) patients. This intervention lowered out-of-pocket spending but did not significantly affect exacerbations or total costs.
Area of Science:
- Health Services Research
- Pulmonary Medicine
- Health Economics
Background:
- High out-of-pocket costs and improper inhaler use negatively impact chronic obstructive pulmonary disease (COPD) patient outcomes.
- Limited evidence exists on interventions addressing these barriers to improve adherence and reduce exacerbations or healthcare spending.
Purpose of the Study:
- To evaluate a national program aimed at reducing cost sharing for COPD maintenance inhalers.
- To assess the impact of medication management services, including inhaler technique education, on patient adherence and outcomes.
Main Methods:
- A randomized clinical trial involving Medicare Advantage enrollees with COPD.
- Participants were randomized to receive an invitation for a program offering reduced inhaler costs ($0 or $10) and medication management services.
- Effects were estimated using intention-to-treat and treatment-on-the-treated analyses, examining outcomes overall and by race.
Main Results:
- The program invitation led to a 3.8 percentage point increase in maintenance inhaler adherence (Proportion of Days Covered).
- Program enrollment resulted in a 15.5 percentage point increase in adherence (55% relative increase) and reduced mean out-of-pocket prescription spending by $203.
- No statistically significant differences were observed in exacerbations, short-acting inhaler fills, or total healthcare spending. The program showed a substantial, though not statistically significant, difference in adherence improvement between Black and White individuals.
Conclusions:
- A program reducing cost sharing and providing medication management services effectively increased maintenance inhaler adherence among COPD patients in Medicare Advantage.
- The intervention successfully lowered out-of-pocket spending for these patients.
- While the program demonstrated potential for reducing racial disparities in adherence, further research is needed to confirm these findings and their clinical significance.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

